| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
80; author reply 2580 |
| issn |
0732-183X
1527-7755 |
| issueIdentifier |
9 |
| pageRange |
2579-80; author reply 2580 |
| publicationName |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
| startingPage |
2579 |
| bibliographicCitation |
Tonkin K. Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer? J Clin Oncol. 2001 May 01;19(9):2579–80; author reply 2580. doi: 10.1200/jco.2001.19.9.2579. PMID: 11331344. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_627f19db76c282edf7a5f02e0ee91f82 |
| date |
2001-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1200/jco.2001.19.9.2579
https://pubmed.ncbi.nlm.nih.gov/11331344 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1527-7755
https://portal.issn.org/resource/ISSN/0732-183X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Is Anastrozole Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer?: Letter 4 |
| discusses |
http://id.nlm.nih.gov/mesh/M0028300
http://id.nlm.nih.gov/mesh/M0021024
http://id.nlm.nih.gov/mesh/M0021911
http://id.nlm.nih.gov/mesh/M0238999
http://id.nlm.nih.gov/mesh/M0014878 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D014230Q000627
http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D009570Q000627
http://id.nlm.nih.gov/mesh/D013629Q000627
http://id.nlm.nih.gov/mesh/D018931Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000077384
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D017698 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2187
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526 |